Albemarle Cash Flow Statement
NYSE: ALBIndustrialsMajor ChemicalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Albemarle free cash flow
In fiscal 2025, Albemarle generated $1.28 billion of operating cash flow and spent $589.8 million on capital expenditures. That left free cash flow of $692.5 million, a free-cash-flow margin of 13.5% of revenue. Albemarle returned $190.5 million to shareholders through dividends, equal to 28% of free cash flow.
Free cash flow covered dividend payments 3.6 times.
Summary generated from market data by MetaCap's automated system. Methodology
Albemarle cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20212022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -465.21M | -1.14B | 1.67B | 2.82B | 199.94M | 446.62M | 604.36M | 739.14M | 99.47M | 680.77M |
| Net Income growth (YoY) | — | -167.97% | -40.66% | +1307.97% | -55.23% | -26.10% | -18.24% | +643.09% | -85.39% | +89.07% |
| Depreciation & Amortization | 658.68M | 588.64M | 429.94M | 300.84M | 254.00M | 231.98M | 213.48M | 200.70M | 196.93M | 226.17M |
| Stock-Based Compensation | 40.27M | 32.14M | 36.55M | 30.47M | 20.12M | 22.84M | 19.68M | 15.23M | 19.40M | 17.03M |
| Change in Working Capital | 263.69M | 1.06B | -353.56M | -1.21B | -15.35M | 128.48M | -109.70M | -149.97M | -122.88M | 28.92M |
| Operating Cash Flow | 1.28B | 687.88M | 1.33B | 1.91B | 344.26M | 798.91M | 719.37M | 546.16M | 303.98M | 735.52M |
| Capital Expenditures | -589.80M | -1.68B | -2.15B | -1.26B | -953.67M | -850.48M | -851.80M | -699.99M | -317.70M | -196.65M |
| Investing Cash Flow | -146.01M | -1.58B | -2.56B | -1.45B | -666.59M | -863.57M | -1.66B | -303.69M | -357.80M | 2.92B |
| Dividends Paid | -190.53M | -188.53M | -187.19M | -184.43M | -177.85M | -161.82M | -152.20M | -144.60M | -140.56M | -135.35M |
| Share Repurchases | — | — | — | — | — | 0 | 0 | -500.00M | -250.00M | 0 |
| Debt Issued | 56.73M | 112.44M | 356.05M | 1.96B | 0 | 452.16M | 1.60B | 0 | 27.00M | 0 |
| Debt Repaid | -505.74M | -112.44M | -28.86M | -705.00M | -1.17B | -250.00M | -175.22M | 0 | -778.21M | -1.25B |
| Financing Cash Flow | -834.19M | 1.24B | 623.91M | 611.89M | 50.21M | 177.26M | 1.04B | -786.53M | -1.09B | -1.58B |
| Net Change in Cash | 425.77M | 302.33M | -609.24M | 1.06B | -307.45M | 133.61M | 57.79M | -581.98M | -1.13B | 2.06B |
| Free Cash Flow | 692.47M | -992.65M | -827.96M | 650.77M | -609.41M | -51.56M | -132.42M | -153.83M | -13.72M | 538.87M |
This table shows 10 annual periods of Albemarle's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ALB's reporting calendar. What is a cash flow statement?